LakeShore Biopharma Co., Ltd (LSB)
NASDAQ: LSB · Real-Time Price · USD
2.940
+0.140 (5.00%)
Dec 2, 2024, 4:00 PM EST - Market closed
LakeShore Biopharma Revenue
In the fiscal year ending March 31, 2024, LakeShore Biopharma had annual revenue of 573.42M CNY, down -16.56%. LakeShore Biopharma had revenue of 135.35M in the quarter ending March 31, 2024, with 27.67% growth.
Revenue (ttm)
573.42M CNY
Revenue Growth
-16.56%
P/S Ratio
0.40
Revenue / Employee
756,488 CNY
Employees
758
Market Cap
56.10M undefined
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 573.42M | -113.78M | -16.56% |
Mar 31, 2023 | 687.20M | 184.25M | 36.63% |
Mar 31, 2022 | 502.95M | 245.93M | 95.69% |
Mar 31, 2021 | 257.02M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionLSB News
- 5 weeks ago - LakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement - PRNewsWire
- 5 weeks ago - LakeShore Biopharma Granted Phase III Clinical Trial Approval to Explore Simplified Regimens for YSJA Rabies Vaccine - PRNewsWire
- 2 months ago - LakeShore Biopharma Provides Fiscal Half Year 2025 Financial Guidance and Reaffirms Fiscal Year 2025 Financial Guidance - PRNewsWire
- 2 months ago - LakeShore Biopharma Announces Results of Extraordinary General Meeting on Share Consolidation - PRNewsWire
- 3 months ago - Lakeshore Biopharma to Hold an Extraordinary General Meeting of Shareholders on September 27, 2024 - PRNewsWire
- 3 months ago - LakeShore Biopharma Announces Leadership Transitions - PRNewsWire
- 3 months ago - LakeShore Biopharma Announces Financial Results for Fiscal Year 2024 - PRNewsWire
- 5 months ago - LakeShore Biopharma to Hold an Extraordinary General Meeting on July 25, 2024, Pursuant to Shareholders' Requisition - PRNewsWire